BioSpace News Archive

Sirona Biochem Corp. announces the termination of the Rodan + Fields agreement for supply and use of TFC-1067 in commercial formulations.

Imagine Lab, Rangam’s full-service internal creative services business, partnered with ReacHER Project, a non-profit organization dedicated to providing single women and mothers affordable urban housing and services.

FAPON announced that Mr. Jielun ZHU, the company’s Chief Financial Officer (CFO) and Chief Investment Officer (CIO), has presented at the 41st Annual J.P. Morgan Healthcare Conference and shared FAPON’s development, achievements and future plans in life sciences.

PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company”), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO’s conference call regarding the presentation of the Report on operations 2022.

Poolbeg Pharma, a leading infectious disease focused biopharmaceutical company, announces the strategic expansion of POLB 001 into oncology.

CARsgen Therapeutics Holdings Limited and Huadong Medicine today announced a collaboration for the commercialization of CARsgen’s BCMA CAR-T product CT053 in mainland China.

WELL Health Technologies Corp. is pleased to announce that Hamed Shahbazi, Chairman and CEO, will be participating in the CIBC Western Institutional Investor Conference.

Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of January 2023, which is payable on February 15, 2023 to shareholders of record at the close of business on January 31, 2023.

Acurx Pharmaceuticals, Inc. is pleased to announce that it has been invited to present at the Emerging Growth Conference on January 25, 2023.